Telesis Bio Inc (TBIO)
1.28
0.00 (0.00%)
USD |
OTCM |
Nov 05, 15:46
Telesis Bio Enterprise Value: 27.81M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 27.81M |
| November 01, 2024 | 27.97M |
| October 31, 2024 | 27.96M |
| October 30, 2024 | 28.20M |
| October 29, 2024 | 28.29M |
| October 28, 2024 | 28.29M |
| October 25, 2024 | 28.24M |
| October 24, 2024 | 28.56M |
| October 23, 2024 | 28.82M |
| October 22, 2024 | 29.37M |
| October 21, 2024 | 29.36M |
| October 18, 2024 | 30.14M |
| October 17, 2024 | 30.07M |
| October 16, 2024 | 30.15M |
| October 15, 2024 | 30.42M |
| October 14, 2024 | 30.47M |
| October 11, 2024 | 30.60M |
| October 10, 2024 | 30.42M |
| October 09, 2024 | 29.85M |
| October 08, 2024 | 29.53M |
| October 07, 2024 | 29.18M |
| October 04, 2024 | 30.07M |
| October 03, 2024 | 30.83M |
| October 02, 2024 | 31.17M |
| October 01, 2024 | 31.48M |
| Date | Value |
|---|---|
| September 30, 2024 | 32.34M |
| September 27, 2024 | 31.27M |
| September 26, 2024 | 32.62M |
| September 25, 2024 | 29.66M |
| September 24, 2024 | 30.35M |
| September 23, 2024 | 31.87M |
| September 20, 2024 | 31.02M |
| September 19, 2024 | 30.74M |
| September 18, 2024 | 27.96M |
| September 17, 2024 | 28.03M |
| September 16, 2024 | 28.29M |
| September 13, 2024 | 28.38M |
| September 12, 2024 | 28.75M |
| September 11, 2024 | 28.56M |
| September 10, 2024 | 32.28M |
| September 09, 2024 | 32.51M |
| September 06, 2024 | 32.34M |
| September 05, 2024 | 32.76M |
| September 04, 2024 | 31.84M |
| September 03, 2024 | 31.61M |
| August 30, 2024 | 31.61M |
| August 29, 2024 | 31.50M |
| August 28, 2024 | 31.54M |
| August 27, 2024 | 31.63M |
| August 26, 2024 | 31.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.537M
Minimum
Jun 29 2022
594.55M
Maximum
Jun 22 2021
77.78M
Average
32.76M
Median
Mar 31 2024
Enterprise Value Benchmarks
| Standard BioTools Inc | 468.31M |
| Ainos Inc | 9.488M |
| Zomedica Corp | 40.25M |
| LENSAR Inc | 53.81M |
| Intelligent Bio Solutions Inc | 0.0571M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.58M |
| Revenue (Quarterly) | 1.55M |
| Total Expenses (Quarterly) | 12.02M |
| EPS Diluted (Quarterly) | -7.62 |
| Gross Profit Margin (Quarterly) | -51.55% |
| Profit Margin (Quarterly) | -811.9% |
| Earnings Yield | -2.40K% |
| Normalized Earnings Yield | -1907.12 |